Fundraising September 15, 2024 – October 1, 2024 About fundraising

ZRX1, the first EGFR inhibitor-capecitabine based...

ZRX1, the first EGFR inhibitor-capecitabine based combi-molecule, requires carboxylesterase-mediated hydrolysis for optimal activity

Ait-Tihyaty, Maria, Rachid, Zakaria, Larroque-Lombard, Anne-Laure, Jean-Claude, Bertrand J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-013-0008-y
Date:
December, 2013
File:
PDF, 706 KB
english, 2013
Conversion to is in progress
Conversion to is failed